NCT05050812

Brief Summary

Grounding (Earthing) refers to the practice of contacting the Earth or a properly installed grounding mat with the body. Previous studies on grounding have shown positive effects body-wide inflammation, acute and chronic pain, and immune system response. Prior studies on the inflammatory process of mild cognitive impairment due to Alzheimer's disease, Alzheimer's disease, and some other dementias have shown connections between immune system dysregulation, inflammatory markers, and severe disease progression. Finding ways to mitigate or turn off the inflammatory response is key to treating mild cognitive impairment due to Alzheimer's disease. The purpose of this study is to evaluate the effects of sleeping grounded on cognition and personal perceptions in participants with a diagnosis of mild cognitive impairment due to Alzheimer's disease as evidenced by a battery of assessments using Cogstate's Cognitive Brief Battery and a qualitative questionnaire. We hypothesize that assessment scores will improve with grounding and that perceptions will positively correlate with an increase in scores. Modulation of risk factors like glucocorticoid resistance, SCI, and immune system dysfunction through grounding may lead to an accessible, natural technique for neurodegenerative disease prevention or treatment.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
8

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2021

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2021

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

September 10, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

September 21, 2021

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
Last Updated

September 24, 2021

Status Verified

September 1, 2021

Enrollment Period

2 months

First QC Date

September 10, 2021

Last Update Submit

September 20, 2021

Conditions

Keywords

Earthingsystemic chronic inflammationgroundingSCIimmune systemsleep qualitymoodpainwell-beingmild cognitive impairment due to Alzheimer's diseaseMCIglucocorticoid resistanceneurodegenerativeCogstate Cognitive Brief BatteryCogstate CBB

Outcome Measures

Primary Outcomes (40)

  • Baseline Psychomotor Function Score

    In this simple reaction time Detection test, a playing card is presented face-down in the center of the screen. After a random interval, the card will turn over so that is it face-up (revealing a Joker card - this same card is used throughout the test). The subject is asked to press the "YES" button as soon as the card turns face-up. Assessed at baseline then weekly for three weeks.

    Baseline

  • Week 1 Psychomotor Function Score

    In this simple reaction time Detection test, a playing card is presented face-down in the center of the screen. After a random interval, the card will turn over so that is it face-up (revealing a Joker card - this same card is used throughout the test). The subject is asked to press the "YES" button as soon as the card turns face-up. Assessed at baseline then weekly for three weeks.

    Week 1

  • Week 2 Psychomotor Function Score

    In this simple reaction time Detection test, a playing card is presented face-down in the center of the screen. After a random interval, the card will turn over so that is it face-up (revealing a Joker card - this same card is used throughout the test). The subject is asked to press the "YES" button as soon as the card turns face-up. Assessed at baseline then weekly for three weeks.

    Week 2

  • Week 3 Psychomotor Function Score

    In this simple reaction time Detection test, a playing card is presented face-down in the center of the screen. After a random interval, the card will turn over so that is it face-up (revealing a Joker card - this same card is used throughout the test). The subject is asked to press the "YES" button as soon as the card turns face-up. Assessed at baseline then weekly for three weeks.

    Week 3

  • Change from Baseline to Week 3 Psychomotor Function Score

    In this simple reaction time Detection test, a playing card is presented face-down in the center of the screen. After a random interval, the card will turn over so that is it face-up (revealing a Joker card - this same card is used throughout the test). The subject is asked to press the "YES" button as soon as the card turns face-up. Assessed at baseline then weekly for three weeks. Change = (Week 3 Psychomotor Function Score - Baseline Psychomotor Function Score).

    Change from baseline to week 3

  • Baseline Attention Score

    In this choice reaction time Identification test, a playing card is presented face-down in the center of the screen. After a random interval, the card will turn over so that is it face-up. Either a red Joker card or black Joker card will be revealed. As soon as the card turns face-up, the subject decides whether the card displayed is red. If the card is red, the subject should press the "YES" button, if it is not red, they should press "NO". Assessed at baseline then weekly for three weeks.

    Baseline

  • Week 1 Attention Score

    In this choice reaction time Identification test, a playing card is presented face-down in the center of the screen. After a random interval, the card will turn over so that is it face-up. Either a red Joker card or black Joker card will be revealed. As soon as the card turns face-up, the subject decides whether the card displayed is red. If the card is red, the subject should press the "YES" button, if it is not red, they should press "NO". Assessed at baseline then weekly for three weeks.

    Week 1

  • Week 2 Attention Score

    In this choice reaction time Identification test, a playing card is presented face-down in the center of the screen. After a random interval, the card will turn over so that is it face-up. Either a red Joker card or black Joker card will be revealed. As soon as the card turns face-up, the subject decides whether the card displayed is red. If the card is red, the subject should press the "YES" button, if it is not red, they should press "NO". Assessed at baseline then weekly for three weeks.

    Week 2

  • Week 3 Attention Score

    In this choice reaction time Identification test, a playing card is presented face-down in the center of the screen. After a random interval, the card will turn over so that is it face-up. Either a red Joker card or black Joker card will be revealed. As soon as the card turns face-up, the subject decides whether the card displayed is red. If the card is red, the subject should press the "YES" button, if it is not red, they should press "NO". Assessed at baseline then weekly for three weeks.

    Week 3

  • Change from Baseline to Week 3 Attention Score

    In this choice reaction time Identification test, a playing card is presented face-down in the center of the screen. After a random interval, the card will turn over so that is it face-up. Either a red Joker card or black Joker card will be revealed. As soon as the card turns face-up, the subject decides whether the card displayed is red. If the card is red, the subject should press the "YES" button, if it is not red, they should press "NO". Assessed at baseline then weekly for three weeks. Change = (Week 3 Attention Score - Baseline Attention Score).

    Baseline to week 4

  • Baseline Visual Learning Score

    In this pattern separation One Card Learning test, a playing card is presented face-down in the center of the screen. After a random interval, the card will turn over so that is it face-up. A regular playing card from a French deck is revealed. As soon as the card turns face-up, the subject must decide whether the current card has been seen before in the test. The subject should press the "YES" button if they have seen the card before in the test, or "NO" if they have not. Assessed at baseline then weekly for three weeks.

    Baseline

  • Week 1 Visual Learning Score

    In this pattern separation One Card Learning test, a playing card is presented face-down in the center of the screen. After a random interval, the card will turn over so that is it face-up. A regular playing card from a French deck is revealed. As soon as the card turns face-up, the subject must decide whether the current card has been seen before in the test. The subject should press the "YES" button if they have seen the card before in the test, or "NO" if they have not. Assessed at baseline then weekly for three weeks.

    Week 1

  • Week 2 Visual Learning Score

    In this pattern separation One Card Learning test, a playing card is presented face-down in the center of the screen. After a random interval, the card will turn over so that is it face-up. A regular playing card from a French deck is revealed. As soon as the card turns face-up, the subject must decide whether the current card has been seen before in the test. The subject should press the "YES" button if they have seen the card before in the test, or "NO" if they have not. Assessed at baseline then weekly for three weeks.

    Week 2

  • Week 3 Visual Learning Score

    In this pattern separation One Card Learning test, a playing card is presented face-down in the center of the screen. After a random interval, the card will turn over so that is it face-up. A regular playing card from a French deck is revealed. As soon as the card turns face-up, the subject must decide whether the current card has been seen before in the test. The subject should press the "YES" button if they have seen the card before in the test, or "NO" if they have not. Assessed at baseline then weekly for three weeks.

    Week 3

  • Change from Baseline to Week 3 Visual Learning Score

    In this pattern separation One Card Learning test, a playing card is presented face-down in the center of the screen. After a random interval, the card will turn over so that is it face-up. A regular playing card from a French deck is revealed. As soon as the card turns face-up, the subject must decide whether the current card has been seen before in the test. The subject should press the "YES" button if they have seen the card before in the test, or "NO" if they have not. Assessed at baseline then weekly for three weeks. Change = (Week 3 Visual Learning Score - Baseline Visual Learning Score).

    Baseline to Week 3

  • Baseline Working Memory Score

    In this N-back One Back test, a playing card is presented face-down in the center of the screen. After a random interval, the card will turn over so that is it face-up. A regular playing card from a French deck is revealed. As soon as the card turns face-up, the subject must decide whether the current card is the same as the previous card. The subject should press the "YES" button if the current card is the same as the one presented immediately before it, or "NO" if it is not the same. Assessed at baseline and weekly for three weeks.

    Baseline

  • Week 1 Working Memory Score

    In this N-back One Back test, a playing card is presented face-down in the center of the screen. After a random interval, the card will turn over so that is it face-up. A regular playing card from a French deck is revealed. As soon as the card turns face-up, the subject must decide whether the current card is the same as the previous card. The subject should press the "YES" button if the current card is the same as the one presented immediately before it, or "NO" if it is not the same. Assessed at baseline and weekly for three weeks.

    Week 1

  • Week 2 Working Memory Score

    In this N-back One Back test, a playing card is presented face-down in the center of the screen. After a random interval, the card will turn over so that is it face-up. A regular playing card from a French deck is revealed. As soon as the card turns face-up, the subject must decide whether the current card is the same as the previous card. The subject should press the "YES" button if the current card is the same as the one presented immediately before it, or "NO" if it is not the same. Assessed at baseline and weekly for three weeks.

    Week 2

  • Week 3 Working Memory Score

    In this N-back One Back test, a playing card is presented face-down in the center of the screen. After a random interval, the card will turn over so that is it face-up. A regular playing card from a French deck is revealed. As soon as the card turns face-up, the subject must decide whether the current card is the same as the previous card. The subject should press the "YES" button if the current card is the same as the one presented immediately before it, or "NO" if it is not the same. Assessed at baseline and weekly for three weeks.

    Week 3

  • Change from Baseline to Week 3 Working Memory Score

    In this N-back One Back test, a playing card is presented face-down in the center of the screen. After a random interval, the card will turn over so that is it face-up. A regular playing card from a French deck is revealed. As soon as the card turns face-up, the subject must decide whether the current card is the same as the previous card. The subject should press the "YES" button if the current card is the same as the one presented immediately before it, or "NO" if it is not the same. Assessed at baseline and weekly for three weeks. Change = (Week 3 Working Memory Score - Baseline Working Memory Score).

    Baseline and Week 3

  • Baseline Sleep Quality Score

    The Personal Perceptions Questionnaire is a self-designed instrument assessing a participant's perception about their average sleep quality, mood, pain, and well-being over the past 7 days. One question is open-ended and uses in vivo coding to create a score about sleep quality while the second question about sleep quality is scaled. Possible scores range from 0 (worst sleep quality) to 10 (best sleep quality).

    Baseline

  • Week 1 Sleep Quality Score

    The Personal Perceptions Questionnaire is a self-designed instrument assessing a participant's perception about their average sleep quality, mood, pain, and well-being over the past 7 days. One question is open-ended and uses in vivo coding to create a score about sleep quality while the second question about sleep quality is scaled. Possible scores range from 0 (worst sleep quality) to 10 (best sleep quality).

    Week 1

  • Week 2 Sleep Quality Score

    The Personal Perceptions Questionnaire is a self-designed instrument assessing a participant's perception about their average sleep quality, mood, pain, and well-being over the past 7 days. One question is open-ended and uses in vivo coding to create a score about sleep quality while the second question about sleep quality is scaled. Possible scores range from 0 (worst sleep quality) to 10 (best sleep quality).

    Week 2

  • Week 3 Sleep Quality Score

    The Personal Perceptions Questionnaire is a self-designed instrument assessing a participant's perception about their average sleep quality, mood, pain, and well-being over the past 7 days. One question is open-ended and uses in vivo coding to create a score about sleep quality while the second question about sleep quality is scaled. Possible scores range from 0 (worst sleep quality) to 10 (best sleep quality).

    Week 3

  • Change from Baseline to Week 3 Sleep Quality Score

    The Personal Perceptions Questionnaire is a self-designed instrument assessing a participant's perception about their average sleep quality, mood, pain, and well-being over the past 7 days. One question is open-ended and uses in vivo coding to create a score about sleep quality while the second question about sleep quality is scaled. Possible scores range from 0 (worst sleep quality) to 10 (best sleep quality). Change = (Week 3 Sleep Quality Score - Baseline Sleep Quality Score).

    Week 3

  • Baseline Pain Score

    The Personal Perceptions Questionnaire is a self-designed instrument assessing a participant's perception about their average sleep quality, mood, pain, and well-being over the past 7 days. One question is open-ended and uses in vivo coding to create a score about pain while the second question about pain is scaled. Possible scores range from 0 (no pain) to 10 (worst pain).

    Baseline

  • Week 1 Pain Score

    The Personal Perceptions Questionnaire is a self-designed instrument assessing a participant's perception about their average sleep quality, mood, pain, and well-being over the past 7 days. One question is open-ended and uses in vivo coding to create a score about pain while the second question about pain is scaled. Possible scores range from 0 (no pain) to 10 (worst pain).

    Week 1

  • Week 2 Pain Score

    The Personal Perceptions Questionnaire is a self-designed instrument assessing a participant's perception about their average sleep quality, mood, pain, and well-being over the past 7 days. One question is open-ended and uses in vivo coding to create a score about pain while the second question about pain is scaled. Possible scores range from 0 (no pain) to 10 (worst pain).

    Week 2

  • Week 3 Pain Score

    The Personal Perceptions Questionnaire is a self-designed instrument assessing a participant's perception about their average sleep quality, mood, pain, and well-being over the past 7 days. One question is open-ended and uses in vivo coding to create a score about pain while the second question about pain is scaled. Possible scores range from 0 (no pain) to 10 (worst pain).

    Week 3

  • Change from Baseline to Week 3 Pain Score

    The Personal Perceptions Questionnaire is a self-designed instrument assessing a participant's perception about their average sleep quality, mood, pain, and well-being over the past 7 days. One question is open-ended and uses in vivo coding to create a score about pain while the second question about pain is scaled. Possible scores range from 0 (no pain) to 10 (worst pain).

    Baseline to Week 3

  • Baseline Mood Score

    The Personal Perceptions Questionnaire is a self-designed instrument assessing a participant's perception about their average sleep quality, mood, pain, and well-being over the past 7 days. One question is open-ended and uses in vivo coding to create a score about mood while the second question about mood is scaled. Possible scores range from 0 (worst mood) to 10 (best mood).

    Baseline

  • Week 1 Mood Score

    The Personal Perceptions Questionnaire is a self-designed instrument assessing a participant's perception about their average sleep quality, mood, pain, and well-being over the past 7 days. One question is open-ended and uses in vivo coding to create a score about mood while the second question about mood is scaled. Possible scores range from 0 (worst mood) to 10 (best mood).

    Week 1

  • Week 2 Mood Score

    The Personal Perceptions Questionnaire is a self-designed instrument assessing a participant's perception about their average sleep quality, mood, pain, and well-being over the past 7 days. One question is open-ended and uses in vivo coding to create a score about mood while the second question about mood is scaled. Possible scores range from 0 (worst mood) to 10 (best mood).

    Week 2

  • Week 3 Mood Score

    The Personal Perceptions Questionnaire is a self-designed instrument assessing a participant's perception about their average sleep quality, mood, pain, and well-being over the past 7 days. One question is open-ended and uses in vivo coding to create a score about mood while the second question about mood is scaled. Possible scores range from 0 (worst mood) to 10 (best mood).

    Week 3

  • Change from Baseline to Week 3 Mood Score

    The Personal Perceptions Questionnaire is a self-designed instrument assessing a participant's perception about their average sleep quality, mood, pain, and well-being over the past 7 days. One question is open-ended and uses in vivo coding to create a score about mood while the second question about mood is scaled. Possible scores range from 0 (worst mood) to 10 (best mood).

    Baseline to Week 3

  • Baseline Overall Well-Being Score

    The Personal Perceptions Questionnaire is a self-designed instrument assessing a participant's perception about their average sleep quality, mood, pain, and well-being over the past 7 days. One question is open-ended and uses in vivo coding to create a score about overall well-being while the second question about overall well-being is scaled. Possible scores range from 0 (worst overall well-being) to 10 (best overall well-being).

    Baseline

  • Week 1 Overall Well-Being Score

    The Personal Perceptions Questionnaire is a self-designed instrument assessing a participant's perception about their average sleep quality, mood, pain, and well-being over the past 7 days. One question is open-ended and uses in vivo coding to create a score about overall well-being while the second question about overall well-being is scaled. Possible scores range from 0 (worst overall well-being) to 10 (best overall well-being).

    Week 1

  • Week 2 Overall Well-Being Score

    The Personal Perceptions Questionnaire is a self-designed instrument assessing a participant's perception about their average sleep quality, mood, pain, and well-being over the past 7 days. One question is open-ended and uses in vivo coding to create a score about overall well-being while the second question about overall well-being is scaled. Possible scores range from 0 (worst overall well-being) to 10 (best overall well-being).

    Week 2

  • Week 3 Overall Well-Being Score

    The Personal Perceptions Questionnaire is a self-designed instrument assessing a participant's perception about their average sleep quality, mood, pain, and well-being over the past 7 days. One question is open-ended and uses in vivo coding to create a score about overall well-being while the second question about overall well-being is scaled. Possible scores range from 0 (worst overall well-being) to 10 (best overall well-being).

    Week 3

  • Change from Baseline to Week 3 Overall Well-Being Score

    The Personal Perceptions Questionnaire is a self-designed instrument assessing a participant's perception about their average sleep quality, mood, pain, and well-being over the past 7 days. One question is open-ended and uses in vivo coding to create a score about overall well-being while the second question about overall well-being is scaled. Possible scores range from 0 (worst overall well-being) to 10 (best overall well-being).

    Baseline to Week 3

Secondary Outcomes (16)

  • Correlation of Change in Psychomotor Function Score and Sleep Quality Score from Baseline to Week 3

    Baseline to Week 3

  • Correlation of Change in Psychomotor Function Score and Pain Score from Baseline to Week 3

    Baseline to Week 3

  • Correlation of Change in Psychomotor Function Score and Mood Score from Baseline to Week 3

    Baseline to Week 3

  • Correlation of Change in Psychomotor Function Score and Overall Well-Being Score from Baseline to Week 3

    Baseline to Week 3

  • Correlation of Change in Attention Score and Sleep Quality Score from Baseline to Week 3

    Baseline to Week 3

  • +11 more secondary outcomes

Study Arms (1)

Grounded

EXPERIMENTAL

All participants will sleep on a grounding mat for at least six hours per 24-hour period.

Device: grounding mat

Interventions

Participants will sleep on an Earthing Elite sleep mat produced and sold by Earthing.com

Also known as: Earthing mat
Grounded

Eligibility Criteria

Age55 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All approved participants must
  • Be at least 55 years of age; all genders and ethnicities;
  • Have English as their primary language or be able to speak, read, and write English fluently; As this is a vulnerable population, this investigator must be able to evaluate understanding and cannot reliably do that with someone who is not fluent in English;
  • Have a current diagnosis of mild cognitive impairment due to Alzheimer's disease made by a medical doctor;
  • Be able to spend at least 6 hours per 24-hour period sleeping or resting on the grounded mat;
  • Be able to legally consent to participating in this study;
  • Agree to allow the researcher to come into their home to setup the equipment and administer the tests;
  • Be able to see well enough to use a laptop to complete electronic testing;
  • Be alert and oriented X 4 based on initial verbal screening and in-person visits;
  • Reside in or around the Greater Austin, Texas, area/Central Texas area;
  • Sleep in a dwelling that is grounded.

You may not qualify if:

  • All approved participants must
  • Not have a diagnosis or conversion to AD or any other type of memory disorder before or during the study period including but not limited to dementia, Lewy body disease, Creutzfeldt-Jakob disease, Parkinson's disease, Huntington's disease, vascular cognitive impairment, frontotemporal dementias, primary progressive aphasia, autoimmune encephalopathy, and normal pressure hydrocephalus;
  • Not have a diagnosis of stable MCI;
  • Not have any prior diagnosis of traumatic brain injury;
  • Not have any history of grounding consistently for more than 60 minutes/day in the past year. This includes natural methods and the use of any grounding devices;
  • Not have any in-the-moment assessment that leads the investigator to believe that the participant is not fully aware or does not understand what is being asked of them. Again, this is a vulnerable population, and I will exclude or cut any participant who shows signs of confusion;
  • Not be taking or have taken in the previous 30 days any of the following medications:
  • daily anti-inflammatories, prescription or over the counter;
  • blood pressure medications (anti-hypertensives);
  • blood thinners (anti-coagulants);
  • e. glucose control medications; f. thyroid medications; g. anti-convulsive medications (no matter the diagnosis); h. any type of monoclonal antibody; i. any type of immunosuppressive, including steroids; j. any type of immunomodulator.
  • Inability to answer the questions in the initial screening interview;
  • Inability to follow instructions.
  • A Note About Medications and Grounding:

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (36)

  • Bostrom G, Freyhult E, Virhammar J, Alcolea D, Tumani H, Otto M, Brundin RM, Kilander L, Lowenmark M, Giedraitis V, Lleo A, von Arnim CAF, Kultima K, Ingelsson M. Different Inflammatory Signatures in Alzheimer's Disease and Frontotemporal Dementia Cerebrospinal Fluid. J Alzheimers Dis. 2021;81(2):629-640. doi: 10.3233/JAD-201565.

  • Brown D, Chevalier G, Hill M. Pilot study on the effect of grounding on delayed-onset muscle soreness. J Altern Complement Med. 2010 Mar;16(3):265-73. doi: 10.1089/acm.2009.0399.

  • Brown R. Effects of Grounding on Body Voltage and Current in the Presence of Electromagnetic Fields. J Altern Complement Med. 2016 Sep;22(9):757-9. doi: 10.1089/acm.2015.0340. Epub 2016 Jul 25.

  • Brown R, Chevalier G, Hill M. Grounding after moderate eccentric contractions reduces muscle damage. Open Access J Sports Med. 2015 Sep 21;6:305-17. doi: 10.2147/OAJSM.S87970. eCollection 2015.

  • Chevalier G. Changes in pulse rate, respiratory rate, blood oxygenation, perfusion index, skin conductance, and their variability induced during and after grounding human subjects for 40 minutes. J Altern Complement Med. 2010 Jan;16(1):81-7. doi: 10.1089/acm.2009.0278.

  • Chevalier G. The effect of grounding the human body on mood. Psychol Rep. 2015 Apr;116(2):534-42. doi: 10.2466/06.PR0.116k21w5. Epub 2015 Mar 6.

  • Chevalier G, Patel S, Weiss L, Chopra D, Mills PJ. The Effects of Grounding (Earthing) on Bodyworkers' Pain and Overall Quality of Life: A Randomized Controlled Trial. Explore (NY). 2019 May-Jun;15(3):181-190. doi: 10.1016/j.explore.2018.10.001. Epub 2018 Oct 11.

  • Chevalier G, Sinatra ST, Oschman JL, Delany RM. Earthing (grounding) the human body reduces blood viscosity-a major factor in cardiovascular disease. J Altern Complement Med. 2013 Feb;19(2):102-10. doi: 10.1089/acm.2011.0820. Epub 2012 Jul 3.

  • Chevalier G, Sinatra ST, Oschman JL, Sokal K, Sokal P. Earthing: health implications of reconnecting the human body to the Earth's surface electrons. J Environ Public Health. 2012;2012:291541. doi: 10.1155/2012/291541. Epub 2012 Jan 12.

  • Cohen S, Janicki-Deverts D, Doyle WJ, Miller GE, Frank E, Rabin BS, Turner RB. Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk. Proc Natl Acad Sci U S A. 2012 Apr 17;109(16):5995-9. doi: 10.1073/pnas.1118355109. Epub 2012 Apr 2.

  • Elkin HK, Winter A. Grounding Patients With Hypertension Improves Blood Pressure: A Case History Series Study. Altern Ther Health Med. 2018 Nov;24(6):46-50.

  • Furman D, Campisi J, Verdin E, Carrera-Bastos P, Targ S, Franceschi C, Ferrucci L, Gilroy DW, Fasano A, Miller GW, Miller AH, Mantovani A, Weyand CM, Barzilai N, Goronzy JJ, Rando TA, Effros RB, Lucia A, Kleinstreuer N, Slavich GM. Chronic inflammation in the etiology of disease across the life span. Nat Med. 2019 Dec;25(12):1822-1832. doi: 10.1038/s41591-019-0675-0. Epub 2019 Dec 5.

  • Ghaly M, Teplitz D. The biologic effects of grounding the human body during sleep as measured by cortisol levels and subjective reporting of sleep, pain, and stress. J Altern Complement Med. 2004 Oct;10(5):767-76. doi: 10.1089/acm.2004.10.767.

  • Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, Ransohoff RM, Herrup K, Frautschy SA, Finsen B, Brown GC, Verkhratsky A, Yamanaka K, Koistinaho J, Latz E, Halle A, Petzold GC, Town T, Morgan D, Shinohara ML, Perry VH, Holmes C, Bazan NG, Brooks DJ, Hunot S, Joseph B, Deigendesch N, Garaschuk O, Boddeke E, Dinarello CA, Breitner JC, Cole GM, Golenbock DT, Kummer MP. Neuroinflammation in Alzheimer's disease. Lancet Neurol. 2015 Apr;14(4):388-405. doi: 10.1016/S1474-4422(15)70016-5.

  • Johansson MM, Marcusson J, Wressle E. Cognitive impairment and its consequences in everyday life: experiences of people with mild cognitive impairment or mild dementia and their relatives. Int Psychogeriatr. 2015 Jun;27(6):949-58. doi: 10.1017/S1041610215000058. Epub 2015 Feb 3.

  • Kravitz BA, Corrada MM, Kawas CH. Elevated C-reactive protein levels are associated with prevalent dementia in the oldest-old. Alzheimers Dement. 2009 Jul;5(4):318-23. doi: 10.1016/j.jalz.2009.04.1230.

  • Lyra E Silva NM, Goncalves RA, Pascoal TA, Lima-Filho RAS, Resende EPF, Vieira ELM, Teixeira AL, de Souza LC, Peny JA, Fortuna JTS, Furigo IC, Hashiguchi D, Miya-Coreixas VS, Clarke JR, Abisambra JF, Longo BM, Donato J Jr, Fraser PE, Rosa-Neto P, Caramelli P, Ferreira ST, De Felice FG. Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer's disease. Transl Psychiatry. 2021 Apr 28;11(1):251. doi: 10.1038/s41398-021-01349-z.

  • Menigoz W, Latz TT, Ely RA, Kamei C, Melvin G, Sinatra D. Integrative and lifestyle medicine strategies should include Earthing (grounding): Review of research evidence and clinical observations. Explore (NY). 2020 May-Jun;16(3):152-160. doi: 10.1016/j.explore.2019.10.005. Epub 2019 Nov 14.

  • Muller E, Proller P, Ferreira-Briza F, Aglas L, Stoggl T. Effectiveness of Grounded Sleeping on Recovery After Intensive Eccentric Muscle Loading. Front Physiol. 2019 Jan 28;10:35. doi: 10.3389/fphys.2019.00035. eCollection 2019.

  • Oschman JL, Chevalier G, Brown R. The effects of grounding (earthing) on inflammation, the immune response, wound healing, and prevention and treatment of chronic inflammatory and autoimmune diseases. J Inflamm Res. 2015 Mar 24;8:83-96. doi: 10.2147/JIR.S69656. eCollection 2015.

  • Oschman JL. Our place in nature: reconnecting with the Earth for better sleep. J Altern Complement Med. 2004 Oct;10(5):735-6. doi: 10.1089/acm.2004.10.735. No abstract available.

  • Oschman JL. Can electrons act as antioxidants? A review and commentary. J Altern Complement Med. 2007 Nov;13(9):955-67. doi: 10.1089/acm.2007.7048.

  • Oschman JL. Charge transfer in the living matrix. J Bodyw Mov Ther. 2009 Jul;13(3):215-28. doi: 10.1016/j.jbmt.2008.06.005. Epub 2008 Jul 30.

  • Oschman JL. Our place in nature: reconnecting with the Earth. J Altern Complement Med. 2010 Mar;16(3):225-6. doi: 10.1089/acm.2009.0656. No abstract available.

  • Oschman JL. Chronic disease: are we missing something? J Altern Complement Med. 2011 Apr;17(4):283-5. doi: 10.1089/acm.2011.0101. Epub 2011 Mar 25. No abstract available.

  • Passi R, Doheny KK, Gordin Y, Hinssen H, Palmer C. Electrical Grounding Improves Vagal Tone in Preterm Infants. Neonatology. 2017;112(2):187-192. doi: 10.1159/000475744. Epub 2017 Jun 10.

  • Pavlov VA, Tracey KJ. The vagus nerve and the inflammatory reflex--linking immunity and metabolism. Nat Rev Endocrinol. 2012 Dec;8(12):743-54. doi: 10.1038/nrendo.2012.189.

  • Sinatra ST, Oschman JL, Chevalier G, Sinatra D. Electric Nutrition: The Surprising Health and Healing Benefits of Biological Grounding (Earthing). Altern Ther Health Med. 2017 Sep;23(5):8-16.

  • Sokal K, Sokal P. Earthing the human body influences physiologic processes. J Altern Complement Med. 2011 Apr;17(4):301-8. doi: 10.1089/acm.2010.0687. Epub 2011 Apr 6.

  • Sokal K, Sokal P. Earthing the human organism influences bioelectrical processes. J Altern Complement Med. 2012 Mar;18(3):229-34. doi: 10.1089/acm.2010.0683.

  • Sokal P, Sokal K. The neuromodulative role of earthing. Med Hypotheses. 2011 Nov;77(5):824-6. doi: 10.1016/j.mehy.2011.07.046.

  • Thayer JF. Vagal tone and the inflammatory reflex. Cleve Clin J Med. 2009 Apr;76 Suppl 2:S23-6. doi: 10.3949/ccjm.76.s2.05.

  • Vinuesa A, Pomilio C, Gregosa A, Bentivegna M, Presa J, Bellotto M, Saravia F, Beauquis J. Inflammation and Insulin Resistance as Risk Factors and Potential Therapeutic Targets for Alzheimer's Disease. Front Neurosci. 2021 Apr 23;15:653651. doi: 10.3389/fnins.2021.653651. eCollection 2021.

  • Chevalier, G, & Sinatra, ST. Emotional Stress, Heart Rate Variability, Grounding, and Improved Autonomic Tone: Clinical Applications. Integrative Medicine. 2011; 10(3): 16-21.

    RESULT
  • Chevalier, G, Melvin, G, & Barsotti, T. One-Hour Contact with the Earth's Surface (Grounding) Improves Inflammation and Blood Flow-A Randomized, Double-Blind, Pilot Study. Health. 2015; 07(08): 1022-1059.

    RESULT
  • Chevalier, G. Grounding the human body improves facial blood flow regulation: Results of a randomized, placebo controlled pilot study. Journal of Cosmetics, Dermatological Sciences and Applications. 2014; 04(05): 293-308

    RESULT

Related Links

MeSH Terms

Conditions

Cognitive DysfunctionSleep Initiation and Maintenance DisordersPainGlucocorticoid Receptor Deficiency

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental DisordersSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Patrice F Jones, CPC

    California Institute of Integral Studies

    PRINCIPAL INVESTIGATOR
  • Anne Huffman, PhD

    California Institute of Integral Studies

    STUDY DIRECTOR

Central Study Contacts

Patrice F Jones, CPC

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Model Details: An interventional, single-group method that lacks random assignment and has no control group but does provide baseline and post-intervention testing.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Student Researcher

Study Record Dates

First Submitted

September 10, 2021

First Posted

September 21, 2021

Study Start

September 1, 2021

Primary Completion

November 1, 2021

Study Completion

December 1, 2021

Last Updated

September 24, 2021

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will not share